Z16b, a natural compound from Ganoderma cochlear is a novel RyR2 stabilizer preventing catecholaminergic polymorphic ventricular tachycardia.

Abstract

Catecholaminergic polymorphic ventricular tachycardia (CPVT) is an inherited, lethal ventricular arrhythmia triggered by catecholamines. Mutations in genes that encode cardiac ryanodine receptor (RyR2) and proteins that regulate RyR2 activity cause enhanced diastolic Ca2+ release (leak) through the RyR2 channels, resulting in CPVT. Current therapies for CPVT are limited. We found that Z16b, a meroterpenoid isolated from Ganoderma cochlear, inhibited Ca2+ spark frequency (CaSF) in R2474S/ + cardiomyocytes in a dose-dependent manner, with an IC50 of 3.2 μM. Z16b also dose-dependently suppressed abnormal post-pacing Ca2+ release events. Intraperitoneal injection (i.p.) of epinephrine and caffeine stimulated sustained ventricular tachycardia in all R2474S/+ mice, while pretreatment with Z16b (0.5 mg/kg, i.p.) prevented ventricular arrhythmia in 9 of 10 mice, and Z16b administration immediately after the onset of VT abolished sVT in 9 of 12 mice. Of translational significance, Z16b significantly inhibited CaSF and abnormal Ca2+ release events in human CPVT iPS-CMs. Mechanistically, Z16b interacts with RyR2, enhancing the "zipping" state of the N-terminal and central domains of RyR2. A molecular docking simulation and point mutation and pulldown assays identified Z16b forms hydrogen bonds with Arg626, His1670, and Gln2126 in RyR2 as a triangle shape that anchors the NTD and CD interaction and thus stabilizes RyR2 in a tight "zipping" conformation. Our findings support that Z16b is a novel RyR2 stabilizer that can prevent CPVT. It may also serve as a lead compound with a new scaffold for the design of safer and more efficient drugs for treating CPVT.

• Authors: Jiang-Fan Wan, Gang Wang, Fu-Ying Qin, Dan-Ling Huang, Yan Wang, Ai-Ling Su, Hai-Ping Zhang, Yang Liu, Shao-Yin Zeng, Chao-Liang Wei, Yong-Xian Cheng, Jie Liu
• Journal: Acta pharmacologica Sinica (Acta Pharmacol Sin) Vol. 43 Issue 9 Pg. 2340-2350 (Sep 2022) ISSN: 1745-7254 [Electronic] United States
• PMID: 35190699 (Publication Type: Journal Article)
• Copyright: © 2022. The Author(s), under exclusive licence to Shanghai Institute of Materia Medica, Chinese Academy of Sciences and Chinese Pharmacological Society.

Chemical References

• Ryanodine Receptor Calcium Release Channel
• Calcium

Topics

• Animals
• Arrhythmias, Cardiac
• Calcium (metabolism)
• Ganoderma
• Humans
• Mice
• Molecular Docking Simulation
• Mutation
• Myocytes, Cardiac (metabolism)
• Ryanodine Receptor Calcium Release Channel (genetics)
• Tachycardia, Ventricular (drug therapy, etiology, prevention & control)